GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Cyclically Adjusted PS Ratio

Chongqing Lummy Pharmaceutical (SZSE:300006) Cyclically Adjusted PS Ratio : 2.54 (As of Jun. 04, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Cyclically Adjusted PS Ratio?

As of today (2025-06-04), Chongqing Lummy Pharmaceutical's current share price is ¥3.71. Chongqing Lummy Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥1.46. Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio for today is 2.54.

The historical rank and industry rank for Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300006' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.51   Med: 3.35   Max: 7.22
Current: 2.46

During the past years, Chongqing Lummy Pharmaceutical's highest Cyclically Adjusted PS Ratio was 7.22. The lowest was 1.51. And the median was 3.35.

SZSE:300006's Cyclically Adjusted PS Ratio is ranked worse than
54.47% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs SZSE:300006: 2.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chongqing Lummy Pharmaceutical's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.187. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥1.46 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chongqing Lummy Pharmaceutical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Cyclically Adjusted PS Ratio Chart

Chongqing Lummy Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.79 4.26 2.39 2.40 2.47

Chongqing Lummy Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 1.53 2.33 2.47 2.35

Competitive Comparison of Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio falls into.


;
;

Chongqing Lummy Pharmaceutical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.71/1.46
=2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Lummy Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Chongqing Lummy Pharmaceutical's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.187/115.1156*115.1156
=0.187

Current CPI (Mar. 2025) = 115.1156.

Chongqing Lummy Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.134 99.500 0.155
201509 0.337 100.500 0.386
201512 0.491 100.600 0.562
201603 0.308 102.200 0.347
201606 0.246 101.400 0.279
201609 0.296 102.400 0.333
201612 0.454 102.600 0.509
201703 0.303 103.200 0.338
201706 0.308 103.100 0.344
201709 0.412 104.100 0.456
201712 0.500 104.500 0.551
201803 0.402 105.300 0.439
201806 0.446 104.900 0.489
201809 0.457 106.600 0.494
201812 0.620 106.500 0.670
201903 0.385 107.700 0.412
201906 0.594 107.700 0.635
201909 0.620 109.800 0.650
201912 0.690 111.200 0.714
202003 0.306 112.300 0.314
202006 0.433 110.400 0.451
202009 0.580 111.700 0.598
202012 0.560 111.500 0.578
202103 0.404 112.662 0.413
202106 0.258 111.769 0.266
202109 0.265 112.215 0.272
202112 0.315 113.108 0.321
202203 0.188 114.335 0.189
202206 0.197 114.558 0.198
202209 0.250 115.339 0.250
202212 0.203 115.116 0.203
202303 0.212 115.116 0.212
202306 0.218 114.558 0.219
202309 0.180 115.339 0.180
202312 0.243 114.781 0.244
202403 0.170 115.227 0.170
202406 0.205 114.781 0.206
202409 0.199 115.785 0.198
202412 0.181 114.893 0.181
202503 0.187 115.116 0.187

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chongqing Lummy Pharmaceutical  (SZSE:300006) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Chongqing Lummy Pharmaceutical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Lummy Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Lai Wen Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines